X-15321541-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000333590.6(PIGA):c.1420G>A(p.Gly474Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000259 in 1,205,066 control chromosomes in the GnomAD database, including 1 homozygotes. There are 94 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G474V) has been classified as Benign.
Frequency
Consequence
ENST00000333590.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGA | NM_002641.4 | c.1420G>A | p.Gly474Arg | missense_variant | 6/6 | ENST00000333590.6 | NP_002632.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGA | ENST00000333590.6 | c.1420G>A | p.Gly474Arg | missense_variant | 6/6 | 1 | NM_002641.4 | ENSP00000369820 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00138 AC: 155AN: 112425Hom.: 0 Cov.: 23 AF XY: 0.00124 AC XY: 43AN XY: 34571
GnomAD3 exomes AF: 0.000382 AC: 70AN: 183338Hom.: 1 AF XY: 0.000324 AC XY: 22AN XY: 67830
GnomAD4 exome AF: 0.000143 AC: 156AN: 1092589Hom.: 1 Cov.: 28 AF XY: 0.000140 AC XY: 50AN XY: 358241
GnomAD4 genome AF: 0.00139 AC: 156AN: 112477Hom.: 0 Cov.: 23 AF XY: 0.00127 AC XY: 44AN XY: 34633
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 13, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at